Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions |
umls-concept:C0020852,
umls-concept:C0021027,
umls-concept:C0025118,
umls-concept:C0025663,
umls-concept:C0032105,
umls-concept:C0085297,
umls-concept:C0205155,
umls-concept:C0445604,
umls-concept:C0450129,
umls-concept:C0596754,
umls-concept:C0680730,
umls-concept:C1148554,
umls-concept:C1260969,
umls-concept:C1514863,
umls-concept:C1522472,
umls-concept:C1551341,
umls-concept:C1552858,
umls-concept:C1552923,
umls-concept:C1552924,
umls-concept:C1556085,
umls-concept:C1704711,
umls-concept:C1705191,
umls-concept:C1879316,
umls-concept:C2603343
|
| pubmed:issue |
6
|
| pubmed:dateCreated |
1996-3-28
|
| pubmed:abstractText |
The working group "Blood Plasma Constituents" of the DGTI has carried out a multicenter study with human immunoglobulins for intravenous administration (IVIG) and a NIBSC serum, with the designation 67/98C, since the European Pharmacopoeia IVIG monograph gives no information for the IgG subclass determination. Aim of the ring study was 1) the determination of the IgG subclass distribution with a standardized method and 2) the determination of the IgG subclass distribution in the NIBSC serum 67/98C and to test if the NIBSC serum coded 67/98C is suited as a reference serum for the IgG subclass determination.
|
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
1019-8466
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
22
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
360-3
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading | |
| pubmed:year |
1995
|
| pubmed:articleTitle |
[IgG subclass distribution in intravenous immunoglobulin products: determination of reproducibility of a method of IgG subclass determination. Ring Study of the "Plasma Blood Components" Section of the German Society of Transfusion Medicine and Immunohematology].
|
| pubmed:affiliation |
Biotest Pharma GmbH, Dreieich, Deutschland.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract,
Multicenter Study
|